Free Trial

Heron Therapeutics (HRTX) SEC Filings & 10K Form

$3.45
+0.01 (+0.29%)
(As of 02:57 PM ET)

Recent Heron Therapeutics SEC Filings

DateFilerForm TypeView
05/07/2024
7:05 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:05 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
1:33 PM
Heron Therapeutics (Filer)
Form DEF 14A
04/29/2024
1:36 PM
Heron Therapeutics (Filer)
Form ARS
04/19/2024
4:48 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:02 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:21 PM
Heron Therapeutics (Filer)
Form PRE 14A
04/19/2024
3:34 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:32 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:46 AM
Deep Track Capital, LP (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
02/06/2024
10:43 AM
FRANKLIN RESOURCES INC (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
01/24/2024
7:01 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
7:58 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:00 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:01 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:01 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:02 PM
Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:03 PM
Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:04 PM
Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:04 PM
Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:05 PM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:19 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:07 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:30 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
4:25 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
1:45 PM
Heron Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
12/06/2023
3:47 PM
BlackRock Inc. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
11/21/2023
11:19 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
9:07 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:36 AM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:37 AM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:10 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
6:57 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
8:14 PM
Heron Therapeutics (Filer)
Form 424B3
08/31/2023
11:15 PM
Heron Therapeutics (Filer)
Form EFFECT
08/24/2023
3:09 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
12:56 PM
Heron Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
07/24/2023
8:12 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2023
5:21 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
4:51 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
4:51 PM
Heron Therapeutics (Issuer)
Szekeres David Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Digitizing the $11T commodities sector with one tiny stock (Ad)

One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector.

It’s an opportunity that likely won’t stay at these levels for long
06/23/2023
3:28 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2023
3:19 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
8:10 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:HRTX) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners